Header Logo

Connection

Megan Lerner to Adrenergic beta-2 Receptor Antagonists

This is a "connection" page, showing publications Megan Lerner has written about Adrenergic beta-2 Receptor Antagonists.
  1. miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun. 2011 Mar 25; 406(4):518-23.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.